DUALE GLP-1/GLP-2-AGONISTEN

Patent europeic · EP3551652 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3551652
Numer da la dumonda
EP17832481
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-12-2017
Publitgà
16-10-2019
Concedì
20-01-2021
Stritgà
23-07-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
Prioritad
DK PA201600756 09.12.2016
Dumonda PCT
PCT/EP2017/082289 11.12.2017
Publicaziun PCT
WO2018/104560 14.06.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.07.2022

  2. 01-12-2021

    Midada

    Published in Swissreg on 01.12.2021

  3. 20-01-2021

    Concedì

    Published in Swissreg on 20.01.2021

Partidas

Possessur

Zealand Pharma A/S

Sydmarken 11, 2860 Søborg, DK

Inventur

EDWARDS, Alistair Vincent Gordon

2860 Soborg, DK

GIEHM, Lise

2860 Soborg, DK

DUE LARSEN, Bjarne

2860 Soborg, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.